tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Butcher SP et al. Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism. 1997 J. Neurosci. pmid:9278529
Hebebrand D et al. Nerve xenograft transplantation. Immunosuppression with FK-506 and RS-61443. 1997 J Hand Surg Br pmid:9222906
Kageyama M et al. FK506-binding proteins regulate smooth muscle contractility by altering neurotransmitter release. 1997 Eur. J. Pharmacol. pmid:9314039
de Paulis A et al. Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs. 1997 Arthritis Rheum. pmid:9082935
Göthel SF et al. An internal FK506-binding domain is the catalytic core of the prolyl isomerase activity associated with the Bacillus subtilis trigger factor. 1997 Eur. J. Biochem. pmid:9063446
Dumont FJ FK506 enhances IL-13 production by T cells activated through CD3/CD28. 1997 Int. Arch. Allergy Immunol. pmid:9363914
Paterson DL et al. Could a herpesvirus mimic tacrolimus-induced leukoencephalopathy? 1997 Ann. Neurol. pmid:9266742
Ahsan N et al. Successful reversal of acute vascular rejection in a renal allograft with combined mycophenolate mofetil and tacrolimus as primary immunotherapy. 1997 Clin Transplant pmid:9113443
Yoshimoto T et al. [Leukoencephalopathy probably caused by tacrolimus hydrate after stem cell transplantation in a girl with MDS 7 monosomy]. 1997 Rinsho Ketsueki pmid:9267167
Singh N et al. Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent. 1997 Clin. Infect. Dis. pmid:9114144
Ito E and Tanaka Y Influences of immunosuppressive agents, FK506 and cyclosporin on systemic Candida albicans infection in mice. 1997 Mycopathologia pmid:9433807
Boucek MM et al. The Registry of the International Society of Heart and Lung Transplantation: first official pediatric report--1997. 1997 J. Heart Lung Transplant. pmid:9436131
Homey B et al. A local lymph node assay to analyse immunosuppressive effects of topically applied drugs. 1997 Eur. J. Pharmacol. pmid:9163567
Ballantyne CM et al. Pathophysiology and treatment of lipid perturbation after cardiac transplantation. 1997 Curr. Opin. Cardiol. pmid:9192484
Vella JP and Sayegh MH Maintenance pharmacological immunosuppressive strategies in renal transplantation. 1997 Postgrad Med J pmid:9338020
Gruessner AC and Sutherland DE Pancreas transplants for United States (US) and non-US cases as reported to the International Pancreas Transplant Registry (IPTR) and to the United Network for Organ Sharing (UNOS). 1997 Clin Transpl pmid:9919390
Odorico JS et al. Advances in pancreas transplantation: the University of Wisconsin experience. 1997 Clin Transpl pmid:9919400
Pirenne J et al. Donor-specific unmodified bone marrow transfusion does not facilitate intestinal engraftment after bowel transplantation in a porcine model. 1997 Surgery pmid:9001555
Felldin M et al. Rescue therapy with tacrolimus (FK 506) in renal transplant recipients--a Scandinavian multicenter analysis. 1997 Transpl. Int. pmid:9002146
Guérette B et al. Prevention by anti-LFA-1 of acute myoblast death following transplantation. 1997 J. Immunol. pmid:9278346
Gaber LW et al. Renal histology with varying FK506 blood levels. 1997 Feb-Mar Transplant. Proc. pmid:9122955
Miller J et al. FK 506 in kidney transplantation: results of the U.S.A. randomized comparative phase III study. The FK 506 Kidney Transplant Study Group. 1997 Feb-Mar Transplant. Proc. pmid:9123008
Jordan ML et al. Five-year experience with tacrolimus rescue for renal allograft rejection. 1997 Feb-Mar Transplant. Proc. pmid:9123009
Cronin DC et al. Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal. 1997 Feb-Mar Transplant. Proc. pmid:9123010
Zhu Y et al. Prolongation of canine renal allograft survival by combining tacrolimus with antimetabolic agents. 1997 Feb-Mar Transplant. Proc. pmid:9123011
Naraghi RM et al. Long-term follow-up of tacrolimus rescue therapy for renal allograft rejection. 1997 Feb-Mar Transplant. Proc. pmid:9123013
Lyne JC et al. Cadaveric renal transplantation against a positive historic crossmatch under tacrolimus immunosuppression: long-term follow-up. 1997 Feb-Mar Transplant. Proc. pmid:9123015
Zucker K et al. Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant patients receiving Prograf and CellCept in combination therapy. 1997 Feb-Mar Transplant. Proc. pmid:9123027
Sellers M et al. Incidence of late acute rejection and progression to chronic rejection in pediatric liver recipients. 1997 Feb-Mar Transplant. Proc. pmid:9123065
Bonatti H et al. Liver transplantation for acute liver failure in children under 1 year of age. 1997 Feb-Mar Transplant. Proc. pmid:9123068
Shapiro R Tacrolimus (FK-506) in kidney transplantation. 1997 Feb-Mar Transplant. Proc. pmid:9123077
Cho JH et al. Chronic rejection in pediatric liver transplantation. 1997 Feb-Mar Transplant. Proc. pmid:9123078
Marino IR et al. Preoperative assessment of risk in liver transplantation: a multivariate analysis in 2376 cases of the UW era. 1997 Feb-Mar Transplant. Proc. pmid:9123079
Rayes N et al. Distribution of lymphocyte subtypes in liver transplant recipients. 1997 Feb-Mar Transplant. Proc. pmid:9123103
Platz KP et al. Impact of immunosuppression and acute rejection on hepatitis B recurrence. 1997 Feb-Mar Transplant. Proc. pmid:9123107
Ko S et al. Predominant role of local immunosuppressive effect in enhanced efficacy of liposomal FK506 in organ transplantation. 1997 Feb-Mar Transplant. Proc. pmid:9123117
Khanna A et al. Cardiac changes at autopsy in adult liver transplant recipients under tacrolimus. 1997 Feb-Mar Transplant. Proc. pmid:9123118
Busuttil RW and Holt CD Tacrolimus (FK506) is superior to cyclosporine in liver transplantation. 1997 Feb-Mar Transplant. Proc. pmid:9123119
Gavlik A et al. Mycophenolate mofetil rescue therapy in liver transplant recipients. 1997 Feb-Mar Transplant. Proc. pmid:9123124
Katoh H et al. Effectiveness of 15-deoxyspergualin on steroid-resistant acute rejection in living related liver transplantation. 1997 Feb-Mar Transplant. Proc. pmid:9123125
Meiser BM et al. Tacrolimus (FK506) proves superior to OKT3 for treating episodes of persistent rejection following intrathoracic transplantation. 1997 Feb-Mar Transplant. Proc. pmid:9123150
Misao T et al. Effect of donor splenocyte transfusion with a simultaneous single injection of tacrolimus on lung allografts. 1997 Feb-Mar Transplant. Proc. pmid:9123153
Morozumi K et al. Electron-microscopic peritubular capillary lesion is a specific and useful diagnostic indicator for chronic rejection of renal allografts showing less specific morphologic lesions in the cyclosporine era. 1997 Feb-Mar Transplant. Proc. pmid:9123167
Zipperle S et al. Impaired T-cell IL-10 secretion and CD4 helper function in liver transplant patients treated with tacrolimus. 1997 Feb-Mar Transplant. Proc. pmid:9123208
Li W et al. High-dose cellular IL-10 exacerbates rejection and reverses effects of cyclosporine and tacrolimus in Mouse cardiac transplantation. 1997 Feb-Mar Transplant. Proc. pmid:9123209
Nakajima H and Oka T Analysis of biochemical and biological functions of Fas-ligand (FasL) and Fas on activated T cells in allo-immune response. 1997 Feb-Mar Transplant. Proc. pmid:9123217
Gassel HJ et al. Selective immunosuppression induces tolerance after liver transplantation: an immunohistochemical and cytofluorographic analysis of the graft and recipient immune system. 1997 Feb-Mar Transplant. Proc. pmid:9123253
Burke GW et al. Donor bone marrow infusion in simultaneous pancreas/kidney transplantation with OKT3 induction: evidence for augmentation of chimerism. 1997 Feb-Mar Transplant. Proc. pmid:9123275
Ota H et al. Intrathymic microchimerism predicts rejection response in allograft recipients. 1997 Feb-Mar Transplant. Proc. pmid:9123279
Tashiro H et al. Correlation of high-level microchimerism with graft acceptance in rat liver transplantation. 1997 Feb-Mar Transplant. Proc. pmid:9123287
Wijnen RM et al. Thymus atrophy in the nonhuman primate by FK506: an immunohistochemical study. 1997 Feb-Mar Transplant. Proc. pmid:9123292
Kumano K et al. Role of the transforming growth factor and monocyte chemoattractant protein in FK506-induced nephropathy in the rat. 1997 Feb-Mar Transplant. Proc. pmid:9123293
Grochowicz PM et al. Synergistic interaction between castanospermine and tacrolimus in a rat heart allograft model. 1997 Feb-Mar Transplant. Proc. pmid:9123296
Guo Z et al. Leflunomide, a potential immunosuppressant for pancreatic islet transplantation. 1997 Feb-Mar Transplant. Proc. pmid:9123314
Walgenbach KJ et al. Immunocytes of composite tissue allografts express elevated levels of TGF beta mRNA and protein during chronic rejection. 1997 Feb-Mar Transplant. Proc. pmid:9123418
Millis JM et al. Tacrolimus treatment of steroid-resistant rejection provides economic advantages compared with OKT3 therapy. 1997 Feb-Mar Transplant. Proc. pmid:9123421
Corry RJ et al. Pancreas transplantation with enteric drainage under tacrolimus induction therapy. 1997 Feb-Mar Transplant. Proc. pmid:9123457
el-Ghoroury M et al. Efficacy and safety of tacrolimus versus cyclosporine in kidney and pancreas transplant recipients. 1997 Feb-Mar Transplant. Proc. pmid:9123461
Hariharan S et al. Long-term renal and pancreas function with tacrolimus rescue therapy following kidney/pancreas transplantation. 1997 Feb-Mar Transplant. Proc. pmid:9123462
Stratta RJ Simultaneous use of tacrolimus and mycophenolate mofetil in combined pancreas-kidney transplant recipients: a multi-center report. The FK/MMF Multi-Center Study Group. 1997 Feb-Mar Transplant. Proc. pmid:9123463
Gruessner AC et al. Solitary pancreas transplants: improving results and factors that influence outcome. 1997 Feb-Mar Transplant. Proc. pmid:9123468
Basadonna GP et al. Pancreas after kidney transplantation: HLA mismatch does not preclude success. 1997 Feb-Mar Transplant. Proc. pmid:9123470
Alessiani M et al. Morphological and functional changes in small-bowel allografts of pigs under combined tacrolimus and mycophenolate mofetil immunosuppression. 1997 Feb-Mar Transplant. Proc. pmid:9123483
Galvao FH et al. Experimental animal model of graft-versus-host disease (GVHD) after small-bowel transplantation: characteristics of the model and application to developing treatment strategies. 1997 Feb-Mar Transplant. Proc. pmid:9123488
Iacona I et al. Mycophenolic acid in combination with FK 506: a pharmacokinetic study in piglets after small-bowel transplantation. 1997 Feb-Mar Transplant. Proc. pmid:9123489
Batten P et al. Effect of cyclosporine A and FK 506 on human T cell responses to xenogeneic and allogeneic endothelium: relative resistance of T cell/porcine endothelial interactions. 1997 Feb-Mar Transplant. Proc. pmid:9123582
Troppmann C et al. FK 506 versus cyclosporine A for steroid-free synergistic combination therapy with rapamycin in a discordant large animal donor xenoislet transplant model. 1997 Feb-Mar Transplant. Proc. pmid:9123585
Matsumiya G et al. Serum interleukin-6 level after cardiac xenotransplantation in primates. 1997 Feb-Mar Transplant. Proc. pmid:9123586
Ohdan H et al. Prolongation of hamster-to-rat liver xenograft survival by donor bone marrow augmentation. 1997 Feb-Mar Transplant. Proc. pmid:9123589
Yamagami S et al. Rejection mechanism and immunosuppression by FK 506 and anti-leukocyte function associated antigen-1 antibody in concordant corneal xenotransplantation. 1997 Feb-Mar Transplant. Proc. pmid:9123598
Markus PM et al. Allogeneic hepatocyte transplantation using FK 506. 1997 Jan-Feb Cell Transplant pmid:9040958
Lo Russo A et al. Cyclosporin A potentiates receptor-activated [Ca2+]c increase. 1997 Jan-May J. Recept. Signal Transduct. Res. pmid:9029487
Billaud EM et al. [Immunosuppression: a case of mucoviscidosis]. 1997 Jul-Aug Therapie pmid:9437888
Garraffo R [Clinical pharmacokinetics and therapeutic monitoring of tacrolimus]. 1997 Jul-Aug Therapie pmid:9437890
Tsubo T et al. Elimination of FK-506 by continuous hemodiafiltration in a liver transplant patient. 1997 Jul-Aug ASAIO J. pmid:9242954
Frezza EE et al. Non-lymphoid cancer after liver transplantation. 1997 Jul-Aug Hepatogastroenterology pmid:9261620
Firdaous I et al. Excretion of tacrolimus glucuronides in human bile. 1997 Jul-Sep Eur J Drug Metab Pharmacokinet pmid:9358202
Guérette B et al. Control of inflammatory damage by anti-LFA-1: increase success of myoblast transplantation. 1997 Mar-Apr Cell Transplant pmid:9142441
Min DI et al. Time-dependent disposition of tacrolimus and its effect on endothelin-1 in liver allograft recipients. 1997 May-Jun Pharmacotherapy pmid:9165550
Healey MC et al. Bovine fallopian tube epithelial cells, adult C57BL/6 mice, and non-neonatal pigs as models for cryptosporidiosis. 1997 Nov-Dec J. Eukaryot. Microbiol. pmid:9508447
Ikeda E et al. Tacrolimus-rapamycin combination therapy for experimental autoimmune uveoretinitis. 1997 Nov-Dec Jpn. J. Ophthalmol. pmid:9509307
DiMartini AF et al. Neuropsychiatric side effects of FK506 vs. cyclosporine A. First-week postoperative findings. 1997 Nov-Dec Psychosomatics pmid:9427854
Carreau A et al. Comparative effects of FK-506, rapamycin and cyclosporin A, on the in vitro differentiation of dorsal root ganglia explants and septal cholinergic neurons. 1997 Nov-Dec Neuropharmacology pmid:9517448
Cox TH et al. Bradycardia associated with intravenous administration of tacrolimus in a liver transplant recipient. 1997 Nov-Dec Pharmacotherapy pmid:9399620
Garattini S Are me-too drugs justified? 1997 Nov-Dec J. Nephrol. pmid:9442441
Resch K and Szamel M Molecular mechanisms of the immunosuppressive action of cyclosporin A. 1997 Sep-Oct Int. J. Immunopharmacol. pmid:9637358
Hara K et al. Implantation of xenogeneic transgenic neural plate tissues into parkinsonian rat brain. 1997 Sep-Oct Cell Transplant pmid:9331504
Van Buren D et al. Renal function in primary liver transplant recipients receiving neoral (cyclosporine) versus prograf (tacrolimus). 1998 Transplant. Proc. pmid:9636566
Gayowski T et al. Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity. 1998 Transplantation pmid:9500623
Bruce DS et al. Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation. 1998 Transplant. Proc. pmid:9636625
Cicalese L et al. Phenotypic and functional characteristics of intestinal intraepithelial lymphocytes during acute rejection of small intestinal allografts. 1998 Transpl. Int. pmid:9561676
Yoshimura N et al. Effect of local immunosuppressive therapy with FK 506 on renal allograft survival in the mongrel dog. 1998 Transplant. Proc. pmid:9838372
Clemann N and Bechter R Effects of rapamycin and FK 506 on rat Sertoli cells in vitro. 1998 Adv. Exp. Med. Biol. pmid:10026935
Koyama T et al. [Effects of various drugs on IL-8 production by eosinophils collected from patients with allergic inflammation]. 1998 Jpn J Antibiot pmid:9597507
Tomono M et al. Inhibitors of calcineurin block expression of cyclins A and E induced by fibroblast growth factor in Swiss 3T3 fibroblasts. 1998 Arch. Biochem. Biophys. pmid:9606972
Tarumi K et al. The plasma FK506-binding protein 12 level is related to acute cellular rejection in small bowel transplantation. 1998 Immunopharmacol Immunotoxicol pmid:9653668
Silber RE et al. Comparison of the effect of FK 506 and alpha/beta-T-cell antibody R73 on transplant vascular sclerosis after heterotopic rat heart transplantation. 1998 Transplant. Proc. pmid:9636398
Ohye H et al. Effects of immunosuppressant agents on growth hormone release and gene expression. 1998 Endocr. J. pmid:9790238
Sussman MA et al. Prevention of cardiac hypertrophy in mice by calcineurin inhibition. 1998 Science pmid:9733519
Matsuda T and Baba A [Response of Na+/Ca2+ antiporter to ischemia and glial/neuronal death]. 1998 Nippon Yakurigaku Zasshi pmid:9551468